Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy
- PMID: 36334265
- PMCID: PMC10158064
- DOI: 10.1093/neuonc/noac248
Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy
Abstract
Background: Ultrahigh dose-rate radiotherapy (FLASH-RT) affords improvements in the therapeutic index by minimizing normal tissue toxicities without compromising antitumor efficacy compared to conventional dose-rate radiotherapy (CONV-RT). To investigate the translational potential of FLASH-RT to a human pediatric medulloblastoma brain tumor, we used a radiosensitive juvenile mouse model to assess adverse long-term neurological outcomes.
Methods: Cohorts of 3-week-old male and female C57Bl/6 mice exposed to hypofractionated (2 × 10 Gy, FLASH-RT or CONV-RT) whole brain irradiation and unirradiated controls underwent behavioral testing to ascertain cognitive status four months posttreatment. Animals were sacrificed 6 months post-irradiation and tissues were analyzed for neurological and cerebrovascular decrements.
Results: The neurological impact of FLASH-RT was analyzed over a 6-month follow-up. FLASH-RT ameliorated neurocognitive decrements induced by CONV-RT and preserved synaptic plasticity and integrity at the electrophysiological (long-term potentiation), molecular (synaptophysin), and structural (Bassoon/Homer-1 bouton) levels in multiple brain regions. The benefits of FLASH-RT were also linked to reduced neuroinflammation (activated microglia) and the preservation of the cerebrovascular structure, by maintaining aquaporin-4 levels and minimizing microglia colocalized to vessels.
Conclusions: Hypofractionated FLASH-RT affords significant and long-term normal tissue protection in the radiosensitive juvenile mouse brain when compared to CONV-RT. The capability of FLASH-RT to preserve critical cognitive outcomes and electrophysiological properties over 6-months is noteworthy and highlights its potential for resolving long-standing complications faced by pediatric brain tumor survivors. While care must be exercised before clinical translation is realized, present findings document the marked benefits of FLASH-RT that extend from synapse to cognition and the microvasculature.
Keywords: FLASH radiotherapy; medulloblastoma; neurocognition; synaptic integrity; vascular sparing.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures






Similar articles
-
Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy.Cancer Res Commun. 2023 Apr 27;3(4):725-737. doi: 10.1158/2767-9764.CRC-23-0117. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37377749 Free PMC article.
-
Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation.Cancers (Basel). 2020 Jun 24;12(6):1671. doi: 10.3390/cancers12061671. Cancers (Basel). 2020. PMID: 32599789 Free PMC article.
-
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.Clin Cancer Res. 2021 Feb 1;27(3):775-784. doi: 10.1158/1078-0432.CCR-20-0894. Epub 2020 Oct 15. Clin Cancer Res. 2021. PMID: 33060122 Free PMC article.
-
Clinical translation of ultra-high dose rate flash radiotherapy: Opportunities, challenges, and prospects.World J Radiol. 2025 Apr 28;17(4):105722. doi: 10.4329/wjr.v17.i4.105722. World J Radiol. 2025. PMID: 40309475 Free PMC article. Review.
-
Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review.Phys Med Biol. 2020 Dec 4;65(23):23TR03. doi: 10.1088/1361-6560/abaa28. Phys Med Biol. 2020. PMID: 32721941 Review.
Cited by
-
Pediatric CNS Radiation Oncology: Recent Developments and Novel Techniques.Curr Oncol. 2025 Mar 20;32(3):180. doi: 10.3390/curroncol32030180. Curr Oncol. 2025. PMID: 40136384 Free PMC article. Review.
-
FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.Nat Cancer. 2025 Mar;6(3):460-473. doi: 10.1038/s43018-025-00905-6. Epub 2025 Feb 5. Nat Cancer. 2025. PMID: 39910249
-
FLASH radiotherapy: bridging revolutionary mechanisms and clinical frontiers in cancer treatment - a narrative review.Ewha Med J. 2024 Oct;47(4):e54. doi: 10.12771/emj.2024.e54. Epub 2024 Oct 31. Ewha Med J. 2024. PMID: 40704005 Free PMC article. Review.
-
Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies.Adv Radiat Oncol. 2023 Dec 17;9(3):101425. doi: 10.1016/j.adro.2023.101425. eCollection 2024 Mar. Adv Radiat Oncol. 2023. PMID: 38379895 Free PMC article.
-
Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy.Front Oncol. 2024 Jan 16;13:1309174. doi: 10.3389/fonc.2023.1309174. eCollection 2023. Front Oncol. 2024. PMID: 38322292 Free PMC article.
References
-
- Bourhis J, Sozzi WJ, Jorge PG, et al. . Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol. 2019;139:18–22. - PubMed
-
- Vozenin MC, De Fornel P, Petersson K, et al. . The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clin Cancer Res. 2019;25(1):35–42. - PubMed